Lexette Topical Foam recalled over manufacturing violations
- Recall date
- January 14, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Mayne Pharma Inc recalls Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville,…
- Recall number
- D-0387-2022
- FDA classification
- Class II
- Brand / firm
- Mayne Pharma Inc
- Sold / distributed
- Nationwide within the United States
Why it was recalled
CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville, NC 27834, NDC 51862-604-50
Get recall alerts
Free email alert whenever Mayne Pharma Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mayne Pharma Inc